Business Description
Paragon Care Ltd
ISIN : AU000000PGC4
Total Employee Number:
508Compare
Compare
Traded in other countries / regions
PGC.AustraliaPXS.Germany IPO Date
1999-10-15Description
Paragon Care Ltd is a medical device company. The company provides medical equipment, devices, and consumables medical products to the healthcare market. The company provides solutions to various healthcare markets, aged care, and veterinary markets. The group is organized into two operating segments: ParagonCare and CH2 Holdings and the majority of its revenues are generated from the CH2 Holdings segment engaged in the distribution of pharmaceuticals, medical consumables, nutritional, and over-the-counter products to the healthcare market.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.08 | |||||
Equity-to-Asset | 0.23 | |||||
Debt-to-Equity | 1.31 | |||||
Debt-to-EBITDA | 10.65 | |||||
Interest Coverage | 0.66 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 3.19 | |||||
Beneish M-Score | -2.74 | |||||
WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 59.9 | |||||
3-Year EBITDA Growth Rate | -0.6 | |||||
3-Year EPS without NRI Growth Rate | -17 | |||||
3-Year Book Growth Rate | -18.4 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 2.63 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 64.36 | |||||
9-Day RSI | 60.18 | |||||
14-Day RSI | 56.22 | |||||
3-1 Month Momentum % | -21.05 | |||||
6-1 Month Momentum % | -31.82 | |||||
12-1 Month Momentum % | -61.54 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.94 | |||||
Quick Ratio | 0.58 | |||||
Cash Ratio | 0.04 | |||||
Days Inventory | 32.24 | |||||
Days Sales Outstanding | 39.6 | |||||
Days Payable | 61.15 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -37 | |||||
Shareholder Yield % | 8.59 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 9.52 | |||||
Operating Margin % | 0.54 | |||||
Net Margin % | -0.38 | |||||
EBITDA Margin % | 1.02 | |||||
FCF Margin % | -0.67 | |||||
OCF Margin % | 0.01 | |||||
ROE % | -4.42 | |||||
ROA % | -1.1 | |||||
ROIC % | 1.73 | |||||
3-Year ROIIC % | 10.29 | |||||
ROC (Joel Greenblatt) % | 3.3 | |||||
ROCE % | 1.58 | |||||
Years of Profitability over Past 10-Year | 8 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Forward PE Ratio | 9.12 | |||||
Price-to-Owner-Earnings | 6.2 | |||||
PS Ratio | 0.07 | |||||
PB Ratio | 0.84 | |||||
EV-to-EBIT | 82.88 | |||||
EV-to-EBITDA | 16.68 | |||||
EV-to-Revenue | 0.17 | |||||
EV-to-Forward-Revenue | 1.19 | |||||
EV-to-FCF | -25.39 | |||||
Price-to-GF-Value | 0.39 | |||||
Price-to-Projected-FCF | 0.91 | |||||
Price-to-Median-PS-Value | 0.12 | |||||
Earnings Yield (Greenblatt) % | 1.21 | |||||
FCF Yield % | -9.57 | |||||
Forward Rate of Return (Yacktman) % | 16.45 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Paragon Care Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil A$) | 3,684.568 | ||
| EPS (TTM) (A$) | -0.009 | ||
| Beta | 1.6231 | ||
| 3-Year Sharpe Ratio | -0.2 | ||
| 3-Year Sortino Ratio | -0.3 | ||
| Volatility % | 39.73 | ||
| 14-Day RSI | 56.22 | ||
| 14-Day ATR (A$) | 0.00947 | ||
| 20-Day SMA (A$) | 0.14475 | ||
| 12-1 Month Momentum % | -61.54 | ||
| 52-Week Range (A$) | 0.125 - 0.41 | ||
| Shares Outstanding (Mil) | 1,655.31 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Paragon Care Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Paragon Care Ltd Stock Events
| Event | Date | Price (A$) | ||
|---|---|---|---|---|
| 0.1:1 Stock Split | 2011-07-19 | 0.38 (+0.00%) | ||
| 0.4:1 Stock Split | 2004-07-26 | 1.64 (+0.00%) | ||
| 0.4:1 Stock Split | 2004-06-22 | 4.10 (+0.00%) | ||
| 0.071429:1 Stock Split | 2003-05-22 | 2.49 (+0.00%) | ||
| 5:1 Stock Split | 2000-06-13 | 132.72 (+0.00%) |
Show
Entries
Paragon Care Ltd Frequently Asked Questions
What is Paragon Care Ltd(ASX:PGC)'s stock price today?
The current price of ASX:PGC is A$0.16. The 52 week high of ASX:PGC is A$0.41 and 52 week low is A$0.13.
When is next earnings date of Paragon Care Ltd(ASX:PGC)?
The next earnings date of Paragon Care Ltd(ASX:PGC) is .
Does Paragon Care Ltd(ASX:PGC) pay dividends? If so, how much?
Paragon Care Ltd(ASX:PGC) does not pay dividend.
Press Release
| Subject | Date | ||
|---|---|---|---|
| Body Vision Medical Receives Regulatory Approval for LungVision® in Australia, Expanding Access to AI-Powered Advanced Imaging for Lung Cancer Diagnosis | 2025-03-11 |
Articles on Paragon Care Ltd
No articles.